in

LATEST:

GE Healthcare highlights need for lifestyle management to prevent and manage cardiovascular diseases

As the region's healthcare professionals gear up for World Heart Day today (September 28), a leading cardiovascular practitioner has advised on the critical need to manage the cardiovascular epidemic, one of the most significant health burdens facing society today.

  • United Arab Emirates: Sunday, September 28 - 2008 at 14:09
  • PRESS RELEASE


    Dumped value of 'ID':
'169955';
Dumped value of 'images_loop':
[];


related stories
Heart disease and stroke is the world's largest killer, claiming 17.5 million lives each year. The aim of World Heart Day is to create public awareness of risk factors for heart disease and stroke and to promote preventive measures. The theme of this year's World Heart Day is 'Know Your Risk!'

Dr. Majid I. Al Fayyadh said that if cardiovascular diseases are not addressed in time, they will become one of the most expensive problems faced by healthcare systems in the region. Today approximately 5% of the population in the Middle East region is over the age of 60 compared to 17% in the US and Western Europe. He cautioned on the need to control the risk factors in time, through lifestyle management, initiating prevention programs and earlier diagnosis.

Dr. Majid I. Al Fayyadh is the Director of Invasive Cardiology Lab Cath Lab and Chairman Electrophysiology Program at King Faisal Specialist Hospital & Research Center, Saudi Arabia, and was a keynote speaker at the GE Healthcare Middle East Media Summit recently held in Dubai.

Dr. Al Fayyadh said:

'What we are seeing today is the tip of the iceberg in terms of cardiovascular disorders across the region. We have to actively look for patients who are at risk if we are to save their lives. For example, out of the 23 million people living in Saudi Arabia, today 80% are under the age of 40. What this means is that in 20 years, many of those people will be 60. We can expect to witness a surge in the incidence of deaths from cardiac diseases.'



Cardiovascular diseases (CVD) are the leading cause of mortality worldwide, and have a major impact on life expectancy, significantly contributing to morbidity and the overall deterioration of quality of life. Some of the major risk factors such as diabetes mellitus, hypertension, dyslipidemia, cigarette smoking, obesity and lack of physical activity are modifiable. According to the World Health Organization (WHO), tobacco will kill over 175 million people between now and the year 2030. Smoking prevalence across the world is on the decline, but is rising in the Middle East.

Dr. Al Fayyadh added: 'The prevalence of diabetes in the region is greater than 20% and this statistic is only going to get worse. There are some things we can change, proven beyond reasonable doubt that they are the causes of disease conditions. We need to control risk factors, initiate cardio prevention programs and increase early detection of cardiac diseases.'

According to WHO statistics, in 2004 ischemic heart disease and cerebrovascular disease, two common types of cardiac disease, were the leading cause of death at 21.9%. By 2030, this is expected to have risen to an alarming 26.3%. In Saudi Arabia, according to statistics, cardiovascular disease amounts for 22% of deaths each year. ICDs (Implantable Cardioverter-defribillators), an advanced version of the pacemaker, can reduce mortality by 30 to 50%, but only 8% of eligible patients worldwide actually receive an ICD.

See Also



request information Log in to request more information from GE Healthcare

Notes and media contacts

About GE Healthcare: GE Healthcare provides transformational medical technologies and services that are shaping a new age of patient care. Our expertise in medical imaging and information technologies, medical diagnostics, patient monitoring systems, performance improvement, drug discovery, and biopharmaceutical manufacturing technologies is helping clinicians around the world re-imagine new ways to predict, diagnose, inform, treat and monitor disease, so patients can live their lives to the fullest.

GE Healthcare's broad range of products and services enable healthcare providers to better diagnose and treat cancer, heart disease, neurological diseases and other conditions earlier. Our vision for the future is to enable a new 'early health' model of care focused on earlier diagnosis, pre-symptomatic disease detection and disease prevention. Headquartered in the United Kingdom, GE Healthcare is a $17bn unit of General Electric Company. Worldwide, GE Healthcare employs more than 46,000 people committed to serving healthcare professionals and their patients in more than 100 countries.

For further information, please contact:
Roisin Lillis / Adnan Abdel-Razzak
ASDA'A Burson-Marsteller
Tel: (+971 4) 334 4550
Ehab Al-Abbadi Posted by Ehab Al-Abbadi
Sunday, September 28 - 2008 at 14:09 UAE local time (GMT+4)

Replication or redistribution in whole or in part is expressly prohibited without the prior written consent of AME Info FZ LLC / Emap Limited.


Disclaimer:
Articles in this section are primarily provided directly by the companies appearing or PR agencies which are solely responsible for the content. The companies concerned may use the above content on their respective web sites provided they link back to http://www.ameinfo.com

Any opinions, advice, statements, offers or other information expressed in this section of the AME Info Web site are those of the authors and do not necessarily reflect the views of AME Info FZ LLC / Emap Limited. AME Info FZ LLC / Emap Limited is not responsible or liable for the content, accuracy or reliability of any material, advice, opinion or statement in this section of the AME Info Web site.

For details about submitting your stories, please read the guide - all content published is subject to our terms and conditions

Sponsored Links

Email newsletters »

Business Directory »

The news you choose

News and Articles »

Today's top stories

 

Current Events »

Advertisement »